# The Role of L-arginine in Polycystic Ovary Syndrome

> **NCT06728644** · NA · COMPLETED · sponsor: **Shanghai 10th People's Hospital** · enrollment: 31 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- L-arginine
- Gut Microbiome

## Interventions

- **DRUG:** L-arginine intervention

## Key facts

- **NCT ID:** NCT06728644
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-14
- **Primary completion:** 2025-07-04
- **Final completion:** 2025-07-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06728644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06728644, "The Role of L-arginine in Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06728644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*